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The major myeloid blood cell lineages are
generated from hematopoietic stem cells by
differentiation through a series of increasingly
committed progenitor cells. Precise character-
ization of intermediate progenitors is important
for understanding fundamental differentiation
processes and a variety of disease states, in-
cluding leukemia. Here, we evaluated the func-
tional in vitro and in vivo potentials of a range of
prospectively isolated myeloid precursors with
differential expression of CD150, Endoglin,
and CD41. Our studies revealed a hierarchy of
myeloerythroid progenitors with distinct line-
age potentials. The global gene expression
signatures of these subsets were consistent
with their functional capacities, and hierarchical
clustering analysis suggested likely lineage re-
lationships. These studies provide valuable
tools for understanding myeloid lineage com-
mitment, including isolation of an early ery-
throid-restricted precursor, and add to existing
models of hematopoietic differentiation by
suggesting that progenitors of the innate and
adaptive immune system can separate late,
following the divergence of megakaryocytic/
erythroid potential.
INTRODUCTION
Hematopoiesis represents a prototype system for the
study of selection, establishment, and restriction of indi-
vidual developmental programs from one common pre-
cursor (Bryder et al., 2006). In this system, hematopoietic428 Cell Stem Cell 1, 428–442, October 2007 ª2007 Elsevier Instem cells (HSCs) have the capacity to both self-propa-
gate as well as differentiate into all blood cell lineages. He-
matopoietic differentiation is amultistep process involving
first the choice of HSC self-renewal versus differentiation,
followed by commitment to different lineage fates. To be
able to cope with the constant and varying challenges to
the blood system, a considerable flexibility needs to ac-
company these events. Because HSCs themselves only
rarely divide (Bradford et al., 1997; Cheshier et al., 1999)
and are limited in numbers, it appears that the immature
progeny of HSCs, which are more numerous and which
harbor differential developmental and proliferative poten-
tials, has been set up to cope with such altered demands
and thereby serve to maintain a primary level of homeo-
static control (Passegue et al., 2005).
Differentiation of immature progenitors into distinct
hematopoietic lineages is contingent on appropriate and
timely execution of specific gene expression programs.
These processes are under both intrinsic and extrinsic
control, which jointly serve to propagate or repress indi-
vidual genes (Laiosa et al., 2006). A wide range of tran-
scription factors are associated with lineage specificity,
and the regulatory networks in which they operate are
being elucidated (Blais and Dynlacht, 2005). The critical
requirement of appropriate control of such factors in oligo-
potent—but normally not self-renewing—progenitors has
been highlighted by the development of leukemias arising
as a consequence of the misappropriate expression of
such transcriptional regulators (Cozzio et al., 2003; Krivt-
sov et al., 2006). However, as such events are relatively
rare, the processes governing their expression are pre-
sumably under tight regulatory control.
Insights into the cellular and molecular mechanisms un-
derlying lineage specification have to a large extent been
provided from studies utilizing in vitro assays (Brady
et al., 1995;Huetal., 1997; Iwasaki et al., 2006).Resultsob-
tained from such work are, however, limited from a physio-
logic point of view, emphasizing the importance ofc.
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proach toward this goal is to determine the cellular stages
that accompany development into individual hematopoi-
etic lineages in the steady-state in vivo situation, followed
by dissection of the functional and molecular properties
of such cells. Using such approaches, the purification of
a common lymphoid progenitor (CLP) that produces lym-
phoid, but not myeloid, progeny (Kondo et al., 1997) and
a common myeloid progenitor (CMP) devoid of lymphoid
but retaining full erythromyeloid competence (Akashi
et al., 2000) suggested a separation of the lymphoid and
myeloid lineages as an early branchpoint in hematopoietic
lineagecommitment. Thismodel hasbeenausefulworking
model but is likely an oversimplification, as suggested
foremost by the lowclonal frequency ofmixedmyeloid col-
onies obtainable from candidate CMP (Akashi et al., 2000;
Iwasaki et al., 2005; Nakorn et al., 2003; Terszowski et al.,
2005; Yoshida et al., 2006). Furthermore, Takano and col-
leagues provided evidence from in vitro paired daughter
experiments of highly purified HSCs, where differentiation
into individual myeloid lineages appeared to bypass a
CMP intermediate (Takano et al., 2004). Moreover, Nutt
and colleagues, using a transgenic knockin approach,
separated candidate CMP based on differential expres-
sion levels of the transcription factor PU.1 and found that
high-level expression of PU.1 in such cells was associated
with granulocytic/macrophage offspring, whereas cells
with low expression mainly produced megakaryocytic/
erythroid progeny,with no evident hierarchical relationship
in between those cells (Nutt et al., 2005). Consistent with
this, the hematopoietic defects associated with PU.1 defi-
ciency indicate a requirement of PU.1 for lymphoid and
myeloid development while being dispensable for the
generation of erythroid and megakaryocytic progenitors
(Scott et al., 1994). Other studies have suggested that
differentiation into the megakaryocytic/erythroid lineages
may be an event upstream or in parallel to the generation
of CMP (Adolfsson et al., 2005; Lai and Kondo, 2006),
by amechanism proposed to involve the transcription fac-
tor Ikaros (Yoshida et al., 2006). Understanding the cellular
and molecular events underlying and accompanying such
processes has broad implications, including increased
understanding of aberrant hematopoiesis—such as the
emergence of different types of leukemias—and for the
development of effective strategies aimed at guiding
differentiation toward therapeutic benefit.
Here, we demonstrate that differential cell-surface
expression of signaling lymphocytic activation molecule
family member 1 (Slamf1/CD150), Endoglin (Eng/CD105),
and Integrin alpha 2b (Itga2b/CD41) allows for the pro-
spective identification of a range of myeloid progenitor
subsets with developmentally restricted lineage poten-
tials, including early lineage-restricted precursors for the
granulocyte/macrophage, erythroid, and megakaryocytic
lineages. Genome-wide expression analyses of these
subsets revealed distinct and ordered expression profiles
of multiple transcription factors and growth factor recep-
tors known to be key regulators of myeloid commitment
and function, thereby illuminating the cellular and molecu-Celar steps associated with definitive restriction into distinct
myeloid fates.
RESULTS
Early Hematopoietic Progenitors Exhibit
Differential Expression of CD150 and Endoglin
In the mouse, Endoglin and CD150 are two cell-surface
molecules associated with high expression in the primitive
HSC compartment (Chen et al., 2002; Kiel et al., 2005). Be-
cause these proteins encode for cell-signaling receptors
with a putative involvement in early HSC fate determina-
tion, we postulated that these markers might also exhibit
differential expression patterns within other hematopoi-
etic progenitor subsets.
To test this, we first screened for the expression of
CD150 and Endoglin by using quantitative RT-PCR
(qRT-PCR) in a wide range of early hematopoietic stem
and progenitor cells. The minor c-kit+LinSca1+ (KLS)
compartment can be resolved into functionally distinct
subsets based on differential expression of CD34 and
flk2 (Adolfsson et al., 2001; Christensen and Weissman,
2001; Yang et al., 2005). When analyzing the three subsets
within the KLS fraction (LT-HSC, CD34flk2; ST-HSC,
CD34+flk2; and MPPflk2+, CD34+flk2+; Figure 1A), we
found highest expression of both Endoglin and CD150
(Figures 1B and 1C) in LT-HSC. Endoglin expression levels
in ST-HSC and MPPflk2+ were approximately half of that
of LT-HSC, whereas CD150 expression was dramatically
reduced in ST-HSC and undetectable in MPPflk2+ cells
(Figures 1B and 1C). Within the CLP fraction expressing
flk2 (CLPflk2+) (Kondo et al., 1997; H. Karsunky, T. Ser-
wold, D. Bhattacharya,M.A. Inlay, and I.L.W., unpublished
data; Figure 1A), we detected low or undetectable expres-
sion levels of Endoglin and CD150, respectively (Figures
1B and 1C). Highly differential expression of these genes
was observed in the originally described myeloerythroid
progenitor fractions (Akashi et al., 2000). These fractions
are jointly characterized by a c-kit+LinSca1 (KLS)
phenotype and can be further separated based on expres-
sion of CD34 and FcgRII/III into common myeloid progen-
itors (CMP, CD34+FcgRlow), granulocyte-macrophage
progenitors (GMP, CD34+FcgRhigh), andmegakaryocyte-
erythroid progenitors (MEP, CD34FcgRlow) (Figure 1A).
Endoglin was highly expressed within the MEP fraction
and at lower levels in CMP and GMP, respectively
(Figure 1B). A similar expression pattern was observed
for CD150, although this gene was nearly undetectable
in GMP (Figure 1C). Expression levels of Endoglin and
CD150 were nearly undetectable in more mature granulo-
cytes and Ter119+ erythroid cells (Figures 1B and 1C).
Next, we phenotypically evaluated previously described
myeloerythroid precursors for the cell-surface expression
of CD150 and Endoglin. This analysis revealed that
although GMP were uniformly low for both these markers,
CMPcould be subdivided into distinct CD150-negative and
-positive populations, whereas MEP consisted of both
CD150-positive and -negative cells as well as a large por-
tion of cells expressing high levels of Endoglin (Figure 1D).ll Stem Cell 1, 428–442, October 2007 ª2007 Elsevier Inc. 429
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A Hierarchy of Early MyelopoiesisFigure 1. Endoglin and CD150 Expression Reveals Phenotypic Heterogeneity of Early Hematopoietic Progenitor Cell Compart-
ments
(A) Phenotypic relationship of early hematopoietic precursors. c-kit-enriched BMcells were costained with antibodies against Lineagemarkers, Sca1,
c-kit, CD34, FcgRII/III, IL7Ra, and flk2 and gated as indicated. Doublets and dead cells were excluded prior to analysis.
(B and C) RNA was extracted from sorted bone marrow LT-HSC, ST-HSC, MPPflk2+, CLP, CMP, GMP, MEP, and Mac1+Gr1+ myeloid and Ter119+
erythroid cells and subjected to quantitative RT-PCR for Endoglin (B) and CD150 (C) for each of the indicated cell types. Data show average relative
expression to unfractionated bone marrow cells ± standard deviation (SD) (after normalization to b-actin).
(D) Representative cell-surface expression of Endoglin and CD150 within the CMP, GMP, and the MEP myeloid progenitor compartments.High-Resolution Fractionation of a Myeloerythroid
Progenitor Cell Compartment
The differential expression of CD150 and Endoglin in the
myeloid progenitor compartment suggested that these
markers might be used to subfractionate functionally dis-
tinct cell types.We therefore developed an isolation proto-
col that simultaneously assessed cell-surface expression
of Endoglin, CD150, FcgRII/III, and CD41 in the KLS
compartment. We included CD41 in our fractionation pro-
tocol, as it has been reported that CD41-high cells within
this compartment are committed to the megakaryocytic
lineage (Nakorn et al., 2003). By contrast, we decided to
omit the use of CD34, as preliminary experiments had
demonstrated that this marker did not add further func-
tional resolution to our seven-color protocol (D.B., unpub-
lished data). Six resolvable cell populations within the
KLS myeloid progenitor compartment could be identi-
fied (Figure 2). These individual populations showed evi-
dent morphological differences, suggesting that they
might be functionally distinct (Figure 2), and will hereafter
be referred to as Pre MegE, Pre CFU-E, CFU-E, MkP, Pre
GM, and GMP based on the subsequent characterization
work in these studies (see below).430 Cell Stem Cell 1, 428–442, October 2007 ª2007 Elsevier IncCD150 and Endoglin Expression on
Myeloerythroid Precursors Is Associated with
Distinct Lineage Outcomes In Vitro
The myeloid progenitor subsets obtainable from the iso-
lation protocol described in Figure 2 were next function-
ally evaluated at the clonal level by in vitro assays. First,
we determined their plating efficiencies. With the excep-
tion of CFU-E, a high proportion of cells from all other
subsets could be induced to proliferate in response to
a combination of early acting cytokines, with plating ef-
ficiencies ranging from 45% to 75% (Figure 3A). Lineage
potential of these cell subsets was evaluated by methyl-
cellulose and agar cultures. In these assays, MkP was
exclusively associated with megakaryocyte generation
(Figure 3B) and thus appears functionally equivalent to
the CD9-positive megakaryocyte-committed precursor
described previously (Nakorn et al., 2003). Consistent
with this, MkP cells were found to express high levels
of CD9 mRNA (D.B., unpublished data), and CD9-
positive MkPs were found to be CD150+, with very sim-
ilar in vitro lineage potentials of these subsets (Figure S1
in the Supplemental Data available with this article
online)..
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A Hierarchy of Early MyelopoiesisFigure 2. High-Resolution Fractionation Murine Myeloid Precursors
Murine bonemarrow cells were stained with antibodies against Sca1, c-kit, CD41 (Itga2b), Endoglin (Eng/CD105), CD150 (Slamf1), FcgRII/III, Ter119,
CD71, and a cocktail of mature blood cell lineage markers (Lin). Cell preparations were also stained with Propidium Iodide, and only live cells are
displayed. Based on this phenotypic analysis, two populations within the KLS compartment and six populations within the KLS compartment
were defined. Morphology of KLS cellular subsets was determined with Grunewald-Giemsa staining of cytospins from sorted fractions. Pro Ery
indicates a previously described proerythroblast population (Socolovsky et al., 2001). Flow cytometric profiles are representative of more than 50
individually stained BM preparations.The GMP described here produced primarily granu-
locytes and/or macrophage colonies (94%, Figure 3B)
and are thus functionally equivalent to the previously
described GMP (Akashi et al., 2000). Within theCeKLSCD41lowFcgRlow/ compartment, Pre GM showed
a remarkably similar clonal lineage output to the FcgR-
positive GMP (82% granulocyte/macrophage clones),
although rare megakaryocytic and/or erythroid elementsll Stem Cell 1, 428–442, October 2007 ª2007 Elsevier Inc. 431
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A Hierarchy of Early MyelopoiesisFigure 3. In Vitro Lineage Potential of Candidate Myeloid Precursor Subsets Separated Based on CD150, Endoglin, and CD41
(A) Indicated cell typeswere single-cell sorted by FACS into liquid cultures as described in the Experimental Procedures. Four, seven, and eleven days
after seeding, cloning frequencies were evaluated of 320–480 individual cells for each population (±SD).
(B and C) To evaluate lineage potentials, indicated cell types were isolated and grown in agar cultures. Seven days after seeding, colony types and
sizes were analyzed after fixation and stainings of intact cultures, as described in the Experimental Procedures. Data are from two experiments, with
six or eight replicates for each population.
(D) Five-hundred cells of indicated cell type were plated in OP9 stroma-supported liquid cultures in the presence of KL, IL3, and EPO. After 5 days of
culture, cells were stained with antibodies against Mac1 and Gr1 and expression was visualized by flow cytometry.were also consistently observed from this cell population
(Figure 3B and C.J.H.P. and D.B., unpublished data). Sin-
gle Pre MegE cells effectively produced megakaryocytic,
erythroid as well as mixed megakaryocyte/erythroid colo-
nies. In contrast, Pre CFU-Es gave rise almost exclusively
to erythroid colonies of various sizes (Figure 3B). Stroma-
supported cultures confirmed that granulocyte/macro-
phage potential of KLSCD41lowFcgRlow/ cells was
restricted to Pre GM (Figure 3D). Lineage potential of
CFU-Es had to be determined in methylcellulose cultures
due to their inability to proliferate in agar cultures (see
below, Figure 6), but we noted that such cells could be in-
duced to proliferate to some extent by using OP9 stroma-
supported cultures (Figure 6).
We next examined the potential of the more primitive
cells upstream in the KLS compartment to see whether
differential expression of CD150 within this compartment
might also be predictive of lineage potential. KLSCD150+
cells, which contain all HSC activity (Kiel et al., 2005), were
found to be associated with multiple colony types, includ-
ing many blast colonies, supporting the notion that this
fraction contains many immature cells that do not mature
fully within the 7 day cell culture protocol employed here
(Figure 3C). Of note was that this fraction also produced
a high portion of clones containing exclusively megakar-432 Cell Stem Cell 1, 428–442, October 2007 ª2007 Elsevier Inyocyte progeny (137 out of 400 cells evaluated, Figure 3C).
By contrast, the KLSCD150 population, which contains
multipotent progenitor but no stem cell activity (Kiel
et al., 2005), essentially lacked megakaryocyte potential
at a clonal level, with only 2 out of 400 cells evaluated
yielding megakaryocytes (Figure 3C). These cells were
nonetheless very efficient in producing granulocyte and/
or macrophage progeny, which were observed in 88%
of evaluated clones (Figure 3C). Taken together, these
data establish that differential expression of CD150 and
Endoglin of early myeloerythroid progenitors is associated
with functional differences in their in vitro lineage poten-
tials, a feature extended to a high degree also to the imma-
ture KLS compartment.
CD150 and Endoglin Expression on
Myeloerythroid Precursors Is Associated
with Distinct Lineage Outcomes In Vivo
We next evaluated the in vivo reconstituting activities of
these cells. KLSCD150+/ myeloid progenitors were
sorted from mice where GFP expression is driven from
a ubiquitously expressed b-actin promoter. Apart from
marking donor white blood cells, this system also permits
readout of mature platelets (Nakorn et al., 2003). Despite
the high-clonal megakaryocyte capacity of CD150+c.
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Cell Type
Number of
Injected Cells
Lineage
Evaluated
Percentage of Donor-Derived Cells
Day 7 Day 14 Day 52
No cells 0 Platelets 0 0 0
Granulocytes 0 0 0
Unfractionated BM 1,500,000 Platelets 3.5 ± 1.5 39.5 ± 3.6 49 ± 2.7
Granulocytes 14.4 ± 10.1 78.5 ± 1.2 71.7 ± 6.2
Myeloid progenitors, CD150 6,000 Platelets 0.15 ± 0.05 0.56 ± 0.72 0
Granulocytes 5.6 ± 4.6 7.3 ± 11.4 0
Myeloid progenitors, CD150+ 1,500 Platelets 0.23 ± 0.04 0.07 ± 0.03 0
Granulocytes 0.1 ± 0.18 0 0
MPP, CD150 300 Platelets 0.3 ± 0.16 3.2 ± 1.6 0
Granulocytes 1.2 ± 0.03 23.1 ± 10.3 0.14 ± 0.02
HSC, CD150+ 75 Platelets 0.43 ± 0.25 20.3 ± 2.7 42.2 ± 8.8
Granulocytes 0.1 ± 0.18 14.8 ± 7.6 55.3 ± 10.9
Sublethally irradiated recipients (450 rad) were transplantedwith 1.53 106 GFP expressing whole BM cells or the indicated number
of isolated stem and progenitor cells estimated to be containedwithin 1.53 106 unfractionated BM cells. At days 7, 14, and 52 after
transplantation, mouse PB was analyzed for the levels of donor platelets and granulocytes, respectively. n = 3 recipients receiving
each cell type and show mean ± SD.myeloid progenitors in vitro (Figure 2B), in vivo platelet
reconstitution was found to be limited with such cells
(Table 1). This was in striking contrast to that observed
for the CD150+ HSC subset, which already showed rapid
and robust platelet recovery 7–14 days after transplanta-
tion of as few as 75 cells (Table 1). Peak production of
granulocytes was observed with CD150 myeloid pro-
genitors 7 days after transplantation, a time point where
CD150 myeloid progenitors reconstituted the granulo-
cytic lineages to significantly higher degrees than ob-
served for either of the control KLS subsets (Table 1). The
failure to produce mature progeny in vivo beyond these
early time points (Table 1) confirms the lack of self-renewal
potential of these myeloid subsets.
To evaluate erythroid potential in vivo, we performed
day 8 spleen colony forming assay (CFU-S8) (Na Nakorn
et al., 2002) and also analyzed reticulocyte recovery after
transplantation. In contrast to transplantation of 200 Pre
MegE cells, which generated large CFU-S8 at high fre-
quency (1/10) (Figure 4A, right), transplantation of 200
Pre GMs gave rise to few CFU-S8 colonies (Figure 4A,
left). We also transplanted lethally irradiated recipients
with cells of each subset in order to gauge their in vivo ery-
throid potential, because rapid erythropoiesis is critical to
circumvent the consequences of a lethal irradiation (Na
Nakorn et al., 2002; Uchida et al., 1994) (Figure 4B). We
observed substantial mortality at 12 days after transplan-
tation; however, enhanced survival was observed in mice
receiving either HSCCD150+ HSCs, Pre MegE, or Pre
CFU-E cells (3/5, 4/8, and 3/8 recipients, respectively;
Figure 4B). Survival above background was not detected
in mice transplanted with Pre GM and GMP, and no retic-
ulocytes were detected in peripheral blood of survivingCemice in these groups (Figure 4B). By contrast, large num-
bers of reticulocytes were observed in mice transplanted
with either Pre MegE (mean 20.7%, n = 4) or Pre CFU-E
(mean 7.2%, n = 3) cells. Neither HSCCD150+ nor CFU-
E produced substantial amounts of reticulocytes by 12
days (Figure 4B). For HSCs, this is consistent with the no-
tion that extensive erythroid generation from low numbers
of primitive HSCs is too slow to be detected 12 days post-
transplantation (Uchida et al., 1994). The failure of CFU-E
cells to generate a substantial amount of reticulocytes in
vivo is consistent with the limited proliferative potential
of CFU-E cells in vitro (Figure 2B).
Taken together, these data establish that the in vitro
lineage potential of these subsets is recapitulated in vivo.
These data also demonstrate that rapid in vivo generation
of platelets is critically contingent on the transfer of imma-
ture, rather than early lineage-restricted MkPs. This is in
contrast to the recoveries of neutrophils and erythrocytes,
which were both rapid and high for the prospectively iso-
lated myeloid subsets associated with these lineages.
Single-Cell Multiplex PCR Fails to Demonstrate
Robust Evidence of Mixed Myeloid Potential
at a Clonal Level
Given the apparently defined lineage potentials of these
fractions, we next performed multiplex single-cell RT-PCR
of Pre MegE, Pre CFU-E, MkP, and Pre GM cells in order
to investigate whether the lineage restriction of these sub-
sets could be traced also at amolecular level. We chose to
investigate the simultaneous expression of myeloperoxi-
dase (Mpo) due to its association with the granulocyte/
macrophage lineages, Mpl (Thrombopoietin receptor)
and Willebrand factor (Vwf) for the megakaryocyticll Stem Cell 1, 428–442, October 2007 ª2007 Elsevier Inc. 433
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like factor 1 (Klf1) as erythroid lineage markers. c-kit
was included in experiments as an internal PCR control,
as all these subsets are characterized by high c-kit
expression.
Ninety percent of single MkP cells expressed Mpl and
most also coexpressed Vwf (Figure 5). Coexpression of
Epor was noted for many (59%) of these cells, consistent
with Erythropoietin being a potent stimulator of megakar-
yocyte development (Metcalf et al., 2002). By contrast,
only 7% of single MkP cells expressed Klf1. These data
are consistent with our functional data, indicating that
MkP cells are restricted to a megakaryocyte fate (Fig-
ure 3B). All Pre CFU-E cells were found to express Epor,
and most of these cells (73%) also coexpressed Klf1.
Some Pre CFU-E cells exhibited Vwf expression (15%);
however, no cells of this fraction were found to express
either Mpl or Mpo, consistent with their restriction to the
erythroid lineage. By contrast, Pre MegE cells, which
Figure 4. In Vivo Erythroid Repopulation Activities of Progen-
itors Separated Based on CD150 and/or Endoglin Expression
(A) Two-hundred Pre GM or Pre MegE cells were transplanted into
lethally irradiated hosts, and 8 days after transplantation, spleens
were harvested and fixed, followed by macroscopic evaluations of
generated colonies.
(B) Two-hundred-fifty candidate HSC or 2500 of the indicated myeloid
progenitor type were transplanted into lethally irradiated hosts, and
after 12 days, peripheral blood was analyzed for reticulocyte levels in
surviving lethally irradiated recipients. For each cell type, eight recipi-
ents were transplanted, and the number of surviving mice is indicated
in addition to levels of reticulocytes in peripheral blood at day 12
(mean ± SD).434 Cell Stem Cell 1, 428–442, October 2007 ª2007 Elsevier InFigure 5. Multiplex Single-Cell Gene Expression of Lineage-
Affiliated Genes of Myeloid Precursors Prospectively Sepa-
rated Based on Differential Expression of CD150, Endoglin,
and CD41
Indicated cell types were single-cell sorted directly into lysis buffer in
96-well PCR plates. After reverse transcription and a two-step nested
PCR approach, c-kit expressing cells (positive control, data not
shown) were analyzed for presence or absence of indicated gene
expression by using a multiplex single-cell RT-PCR approach. Each
line indicates a single cell, and presence of transcripts in individual
cells is shown by uniquely colored dots for indicated genes. In these
experiments, three to six cells of each fraction were positive for c-kit
but negative for all other genes; these cells have been omitted from
analysis.c.
Cell Stem Cell
A Hierarchy of Early Myelopoiesisproduce both erythroid megakaryocytic as well as a few
mixed megakaryocyte/erythroid clones (Figure 3B), ex-
pressed Epor, Mpl, and Klf1 in various combinations but
only rarely (8% of cells) expressed Mpo, consistent with
their commitment to a megakaryocyte/erythroid fate. In
striking contrast, 97% of single Pre GM cells expressed
Mpo, 27% of which also coexpressed Mpl. Of all the cell
types investigated, only a few scattered cells were found
to simultaneously express granulocyte/macrophage with
megakaryocytic- and erythroid-oriented genes, and no
cell (0/323 cells scored) was found to simultaneously ex-
press all of the investigated genes.
Taken together, these data are in agreement with the
functional properties associated with each of the investi-
gated cell types. Importantly, these experiments provide
little evidence that a substantial fraction of the candidate
myeloid progenitors evaluated here displayed transcrip-
tional properties associated with mixed myeloid lineage
potential (megakaryocytic/erythroid/granulocytic/macro-
phage).
Proliferation and Differentiation In Vitro Suggest
a Hierarchical Structure of Murine Myeloid
Progenitors
In order to delineate the hierarchical relationship between
these myeloid progenitors, we analyzed the burst sizes of
colonies generated from the described progenitor frac-
tions, reasoning that higher proliferative activity correlates
with primitiveness (Baines et al., 1982). These experi-
ments demonstrated that clone sizes obtained from Pre
GM cells were larger than those obtained from GMP
(Figure 6A). Moreover, in short-term liquid cultures, Pre
GM cells rapidly generated phenotypic GMP, whereas
GMP could not generate phenotypic Pre GM (C.J.H.P.
and D.B., unpublished data). These results are consistent
with the interpretation that Pre GM lie developmentally
upstream of GMP.
Similarly, erythroid clone sizes were larger from Pre
MegE than for Pre CFU-E, suggesting a hierarchical pro-
gression fromPreMegE to Pre CFU-E (Figure 6B). Consis-
tent with this, clones obtained from Pre MegE were found
to contain CFU-E-like clusters at day 7 (D.B., unpublished
data). As clonal liquid culture assays did not support
growth of CFU-E (Figure 2B), we compared proliferative
potentials of Pre CFU-E and CFU-E with methylcellulose
cultures. CFU-E gave primarily rise to single-cluster
CFU-Es, whereas Pre CFU-E produced not only CFU-Es
(many which comprised two to three clusters) but also
some larger sized BFU-Es (Figure 6C). KLS cells with
robust erythroid potential were also cultured in stroma-
supported liquid media. After 4 days of culture, 9.3% of
cells generated from Pre MegE still exhibited an immature
Ter119-c-kit+ phenotype, whereas these cells were de-
tected at progressively decreased levels from cultures
with Pre CFU-E and CFU-E cells (Figure 6D). These exper-
iments established that Pre MegE can generate pheno-
typic Pre CFU-E and CFU-E, and that Pre CFU-E can gen-
erate CFU-E, and thereby suggest a developmental
progression of early erythropoiesis wherein Pre MegECellgive rise to Pre CFU-E, which in turn differentiates into
CFU-E.
We next assessed the proliferative capacities of cells
with megakaryocyte potential. MkPs generated single
megakaryocytes in 85% of wells (Figure 6E) and only
rarely larger clones, indicating their proximity and restric-
tion to a mature megakaryocytic fate. In contrast, mega-
karyocyte colonies generated from Pre MegE generated
two or more cells in 40% of the wells, suggesting a hierar-
chical progression fromPreMegE toMkP. Consistent with
these observations, 85% of megakaryocyte containing
clones generated from single CD150+ HSCs gave rise to
two or more cells and generated a substantially higher
number of large megakaryocyte clones compared to
both Pre MegE and MkP (Figure 6E).
Analysis of Global Gene Expression Patterns
Reveals Specific Genetic Programs Associated
with Lineage Restriction within the Early
Myeloerythroid Compartment
Having established the distinct functional properties
associated with subsets of early myeloid progenitors, we
undertook a global gene expression approach in order
to objectively evaluate their molecular identities and to
evaluate the transcriptional changes accompanying early
unilineage megakaryocytic and erythroid restriction.
To this end, we FACS purified 2,000–10,000 Pre MegE,
Pre GM, MkP, and Pre CFU-E cells, followed by RNA
extraction, reverse transcription, linear amplification, and
hybridization to Affymetrix 430.2 arrays, which contain
46,000 probe sets representing 36,000 genes. In addi-
tion, we also generated an expression signature of CLPflk2+
cells (H. Karsunky, T. Serwold, D. Bhattacharya, M.A.
Inlay, and I.L.W., unpublished data). With this approach,
we were aiming at simultaneously exposing such genes
that are involved in early lymphoid versus myeloid fate
decisions.
After filtration (see Experimental Procedures), 3184
genes remained and were subjected to hierarchical clus-
tering. This analysis confirmed the distinct gene expres-
sion characteristics of the various progenitor subsets
and suggested an internal relationship of these cell types
based on their transcriptional similarities (Figure 7A).
Next, we focused our analyses more directly on the
transcriptional changes associated with early lineage es-
tablishment. To this end, we investigated the genes pass-
ing the above filtering criterion and investigated genes
with a 2-fold or higher expression change between CLP,
Pre GM, and Pre MegE (with a 90% confidence interval).
These analysis criteria revealed that only 623 probe sets
that were differentially regulated within these cell types
(298 associated with Pre MegE, 147 with Pre GM, and
178 with CLPflk2+) (Figure 7B, full gene lists from these
analyses can be found in Table S2). In order to evaluate
the quality of these data by independent means, we per-
formed quantitation real-time PCR (qRT-PCR) of several
of the genes identified by our microarray approaches,
including Gata1, Gata2, EpoR, granulocyte-colony stimu-
lating factor 3 receptor 1 (G-csfr), macrophage colonyStem Cell 1, 428–442, October 2007 ª2007 Elsevier Inc. 435
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Differential Expression of CD150, Endoglin, and CD41
(A and B) Single Pre GM, GMP, Pre MegE, and Pre CFU-E cells were plated in IMDM supplemented with FCS, KL, IL3, and EPO in 60-well Terasaki
plates by using a flow cytometry coupled single-cell depositor. Seven days after initiation of cultures, clone sizes were determined from cells gen-
erating either (A) granulocyte/macrophage or (B) erythroid progeny, respectively, and scored according to criteria as described previously (Bryder
and Jacobsen, 2000).
(C) Pre CFU-E and CFU-E were plated at low densities in methylcellulose. CFU-Es were enumerated at day 3 and BFU-E at day 7.
(D) Five-hundred cells of indicated cell type were plated in stroma (OP9)-supported liquid cultures in the presence of kit ligand, Interleukin 3, and
Erythropoietin. After 5 days of culture, cells were stainedwith antibodies against c-kit, Ter119, Endoglin, and CD150, and expression of thesemarkers
on generated progeny was visualized by flow cytometry.
(E) HSC, PreMegE, andMkPwere plated at low densities in agar cultures. After 7 days of culture, the number of acethylcholinesterase-positivemega-
karyocytes was determined in colonies containing such cells.stimulating factor 1 (M-csfr), CCAAT/enhancer binding
protein alpha (Cebpa), Terminal deoxynucleotidyl transfer-
ase (Dntt), immunoglobulin heavy chain 6 (Igh-6/sterile
IgM), and Notch 1, which showed that the qRT-PCR436 Cell Stem Cell 1, 428–442, October 2007 ª2007 Elsevierdata were in close agreement with the microarray data
(Figure 7C).
When exploring the differentially expressed genes as-
sociated with early lineage restriction, we could identifyInc.
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tion to a range of genes associated with lineage specific-
ity. For instance, for the Pre MegE cluster, we observed
high expression of Glycoprotein 1 (both a and b polypep-
tides), vonWillebrand factor (Vwf), Thrombin receptor, and
Glycoprotein 5: genes with nonredundant functions spe-
cific to platelet function. Expression levels of these genes
were further elevated in MkP (Table S2), in agreement with
the notion that the transition of Pre MegE into lineage-
restricted MkP is accompanied by a strengthening of the
genetic program associated with terminal differentiation.
Also, well-characterized transcriptional regulators of mega-
karyocyte development, including Gata2 and Zfpm1
(Fog1), exhibited this pattern of expression, although sig-
nificant expression was noted for both of these genes also
in the Pre CFU-E population. Similarly, multiple genes
associated with erythroid specification, including Gata1,
Tal1 (Scl), Gfi1b, Kruppel–like factor 1 (Klf1), and Epor
were robustly expressed in Pre MegE cells and further
elevated in Pre CFU-E (Table S2).
Of the genes associated with high expression in Pre GM
cells, we observed several growth factor receptors asso-
ciated with neutrophil/macrophage production, including
G-csfr, M-csfr, and the b common chain for Interleukin-
3, Interleukin-5, and GM-CSF (Figures 7B and 7C). Ele-
vated expression of the transcription factor Cebpa was
also associated with this subset, as was expression of
lysozyme and Mpo, all well-characterized neutrophil and
macrophage effector molecules (Borregaard and Cow-
land, 1997). A somewhat intriguing expression pattern
was observed for a number of the genes associated with
the Pre GM subset, including for instance M-csfr and G-
csfr; as we could observe clear expression of such genes
also in CLPflk2+. Conversely, several genes with high
expression in CLPflk2+ cells, including Dntt, Notch 1, and
sterile IgM, were expressed also in Pre GM cells (Fig-
ure 7C). These data are consistent with the lineage prox-
imity of CLPflk2+ and Pre-GM cells that emerged from
the hierarchical clustering analysis (Figure 7A).
Based on the large number of genes previously shown
to be associated with myeloid lineage restriction and var-
ious myeloid effector cell functions, we conclude that the
global expression patterns obtained here are in striking
accordance with the functional behavior of these subsets.
Taken together, these data illuminate the molecular cir-
cuitry underlying the specification of distinct myeloid fates
and provide previously unknown insights into the lineage
relationship existing between different progenitors. More-
over, in addition to the many genes with well-established
roles in fate specification, these data reveal a large num-
ber of candidate myeloid specification genes that have
not been previously implicated in such fate decisions.
DISCUSSION
Unraveling the stepwise differentiation processes that
lead from multipotent stem cells to mature effector cells
is critically important for understanding both normal and
neoplastic hematopoiesis. The isolation of progenitorsCewith well-defined functional and molecular properties is
an important step toward this goal. In this work, we have
explored the processes of myeloid cell differentiation
and reveal a number of novel intermediate progenitors
(Figure 7D). Our data showing the potent in vivo reconsti-
tuting activities of several of these subsets in the short-
term transplantation setting highlight their potential utility
for cellular therapy, although the limited in vivo platelet
reconstitution potential obtained from committed MkPs
suggest a unique requirement for transplantation of more
immature precursors to ensure robust in vivo generation
of this lineage.
Our studies demonstrate distinct transcription patterns
associated with the progenitor subsets identified in this
work. In accordance with their functional properties,
such patterns are characterized by differential expression
of multiple established regulators for the individual mye-
loid lineages. In addition to the well-characterized lineage
specification genes we identified, it is likely that many of
the lesser known genes we found to be enriched in each
of the progenitor subsets will likely play important roles
in lineage specification, which may be borne out of future
studies.
The possibility of generating genome-wide transcrip-
tional signatures of prospectively isolatable and well-
defined cellular subsets has provided a means through
which lineage relationships can be correlated to an entire
transcriptome. Such approaches uncovered an unexpect-
edly close relationship between progenitors committed
toward lymphoid and granulocyte/macrophage lineages
as opposed to cell populations containing merely mega-
karyocytic/erythroid potentials. The clustering of the Pre
MegE and CFU-E against MkP cells at this branch could
be explained by the presence of a higher number of
erythroid-primed or -committed cells within the hetero-
geneous Pre MegE, giving this population more of an
erythroid than a megakaryocytic global transcription sig-
nature. In addition to genome-wide clustering analysis,
the close lineage relationship between CLP and Pre-GM
progenitors was supported by the expression of individual
genes such as sterile IgM and Dntt (TdT) transcripts in Pre
GM cells, transcripts traditionally associated with lympho-
poiesis (Medina et al., 2001). In parallel, significant expres-
sion of myeloid-oriented growth factor receptors such as
M-csfr and G-csfr were highly expressed in CLPflk2+.
Evidence for a developmental relationship between the
lymphoid and granulocyte/macrophage lineages was re-
cently provided by observations of residual granulocyte/
macrophage capacity of isolated lymphoid progenitors
(Balciunaite et al., 2005; Rumfelt et al., 2006) and by the
identification of early progenitors with robust lymphomye-
loid but little megakaryocyte/erythroid potential (Adolfs-
son et al., 2005; Lai and Kondo, 2006). Those studies sug-
gested that the megakaryocytic and/or erythroid lineages
can diverge prior to a lymphoid/myeloid branchpoint
(CMP/CLP), a view that is in accordance with the data pre-
sented here and proposed more than 10 years ago based
primarily on the hematopoietic defects in PU.1-deficient
mice (Singh, 1996). On the other hand, one must bell Stem Cell 1, 428–442, October 2007 ª2007 Elsevier Inc. 437
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A Hierarchy of Early MyelopoiesisFigure 7. Genome-wide Expression Signatures of Early Myeloid Progenitors and Developmental Position of Precursors Described
in This Work
RNA was extracted from 2,000–10,000 cells of each indicated fraction, followed by linear amplification, and hybridized to Affymetrix 430A 2.0 arrays.
(A) Clustering of cell fractions based on total transcripts on arrays. Replicate arrays were pooled, followed by gene filtering (0.5 < SD/mean < 1000 and
present calls in at least one subset) to eliminate noise and genes not differing in expression in between samples. Filtering resulted in 3184 probe sets,
on which overall clustering was performed.438 Cell Stem Cell 1, 428–442, October 2007 ª2007 Elsevier Inc.
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others do observe rare cells in the myeloid progenitor
compartment investigated here that possess mixed mye-
loid lineage potential. In fact, it appears likely to us that the
frequency of such cells might be even higher, as improve-
ments in marker detection (i.e., for Sca1) do not justify
direct comparison to original studies of CMP.
Several reports have demonstrated that lineage conver-
sion can occur in already lineage committed cells, most
convincingly evidenced by the presence of immunoglobu-
lin or T cell receptor rearrangements in myeloid progeny
(Drynan et al., 2005; Kondo et al., 2000; Xie et al., 2004).
Such studies have implicated the possibility of lineage
plasticity to accompany hematopoietic progenitor biology.
When seeded in vitro, lineage switching of CLP into the
granulocyte/macrophage lineages could only be induced
within the first 2 days after plating, but not at later time
points (Kondo et al., 2000). Similar observations were re-
cently made for Cebpa-mediated conversion of CLP and
MEP, with a notably wider time window through which
conversion could be achieved for megakaryocyte precur-
sors (Fukuchi et al., 2006). Such data suggest that varying
degrees of lineage plasticity accompany initial phases of
lineage commitment and may relate to the presence of
residual transcripts or transcript accessibility. However,
it is at this point unclear whether such developmental
plasticity represents a physiologic-utilized mechanism for
regulating homeostasis or if it is strictly an experimentally
introduced phenomenon.
Although correlative, the finding of genetic similarities
between early lymphoid and early granulocytic/macro-
phage precursors could help to explain the origin of cer-
tain lymphomyeloid biphenotypic leukemias, which do
not appear to involve the erythroid and/or megakaryocytic
lineages (Imamura et al., 2002; Wang et al., 2005). Our
data would suggest that such leukemias, rather than
reflecting reactivation of previously repressed genetic
programs, might be a consequence of transformation of
normally occurring precursors with limited or no megakar-
yocytic/erythroid potential. The finding of common tran-
scriptional features at several stages of differentiation
(either CLP, early granulocytic/macrophage precursors,
or an early bipotent precursor with the ability to generate
both adaptive and innate immune components) broadens
the developmental window where immortalization events
might display such biphenotypic properties.
In conclusion, the results presented herein have defined
a panel of myeloid progenitor cell intermediates that offer
an unprecedented resolution of early myelopoiesis. These
studies set the stage for their further exploration in the
study of mechanisms governing both normal and aberrantCellmyelopoiesis and also should provide valuable insight for
the identification of corresponding subsets in the human
system. This might be directly applicable for markers
such as CD150 and Endoglin, as development into mature
platelets from HSCs appears to be characterized by con-
tinuous CD150 expression, and human platelets are also
CD150 positive (Nanda et al., 2005), whereas subsets of
early human erythroid progenitors are characterized by
Endoglin expression (Rokhlin et al., 1995). The identifica-
tion of the first lineage-restricted precursors of the ery-
throid, granulocytic/monocytic, and megakaryocytic line-
ages should be useful to dissect the processes governing
entry, proliferation, and maturation into these lineages.
EXPERIMENTAL PROCEDURES
Mice
Two- to three-month-old b actin GFP transgenic mice (Wagers et al.,
2002) or C57BL/6 mice (either CD45.2 or CD45.1) were used through-
out these studies. Mice were maintained at the Lund University and
Stanford University animal facilities. All mice procedures were per-
formed with consent from the local ethics committees.
Purification of Hematopoietic Stem and Progenitor Cells
Hematopoietic stem and myeloid progenitor cells were isolated by
staining of unfractionated bone marrow cells with unconjugated anti-
bodies against CD4, CD5, CD8, B220, Ter119, Gr1, and Mac1 and
visualized with fluorochrome-conjugated goat and rat antibodies. Lin-
eage-stained cells were next c-kit-enriched by using c-kit-conjugated
magnetic beads (Miltenyi, Bergisch Gladbach, Germany). c-kit-en-
riched cells were subsequently stained with antibodies against Sca1,
c-kit, FcgRII/III (FcgR), CD41 (Itga2b), CD150 (Slamf1), and Endoglin
(Eng/CD105) or for investigation of CD150 and Endoglin expression
on previously described myeloid progenitor cell fractions, with anti-
bodies against lineage markers, Sca1, c-kit, CD34, FcgRII/III, CD150,
and Endoglin. Propidium Iodide (Molecular Probes) or 7-Amino-Acti-
nomycin D (7-AAD; Sigma-Aldrich Co., St. Louis, MO) was used to ex-
clude dead cells. Common lymphoid progenitor cells were obtained by
sorting cells with a lineage-negative, Sca1 low, ckit low, IL7Ra positive,
flt3 positive phenotype. Antibody clones and suppliers are indicated in
Table S1. Cells were maintained on ice when possible through all pro-
cedures and were sorted on FACS Aria cell sorters (Becton Dickinson).
All flow cytometry and FACS data were analyzed with FlowJo software
(Tree Star, Ashland, OR). In some experiments, indicated cell popula-
tions were transferred on slides by using a cytospin centrifuge and
subsequently stained with May-Gru¨nwald/Giemsa-staining (Sigma-
Aldrich) for morphological examination.
In Vitro Culture Assays
Freshly isolated unfractionated BM cells and sorted hematopoietic
stem and progenitor cells were cultured with liquid and semisolid
culture conditions (at 37C, 98% humidity, and 5% CO2) to evaluate
single-cell clonogenic activity and lineage potentials of isolated cell
populations. For clonogenic liquid cultures, single cells (using a sin-
gle-cell depositor coupled to a FACS Aria) were sorted into Terasaki
plates in 20 ml medium (IMDM) supplemented with 20% prescreened(B) A heat map is displayed with genes that were 2-fold or higher differentially expressed between Pre MegE versus Pre GM and CLP, Pre GM versus
Pre MegE and CLP, and CLP versus Pre GM and Pre MegE. Red indicates high expression; white, intermediate; and blue, low-level gene expression.
A selection of individual genes found in each gene cluster is presented next to the heat map display.
(C) qRT-PCR was performed on selected genes identified by our microarray approach. To be able to directly correlate qRT-PCR data with those
expression patterns on arrays, array data was also normalized internally to b-actin (± SD). When genes were called absent from one or more popu-
lation on arrays, the corresponding expression value for such arrays was subtracted from all other samples.
(D) Proposedmyeloid developmental scheme and cell surfacemarker changes associated with the precursors studied in detail in this work (gray box).Stem Cell 1, 428–442, October 2007 ª2007 Elsevier Inc. 439
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A Hierarchy of Early Myelopoiesisfetal calf serum (FCS; Hyclone, Logan, UT), 0.1 mM b-mercaptoetha-
nol and recombinant growth factors c-kit Ligand (KL; 50 ng/ml Pepro-
Tech Inc, Rocky Hill, NJ), Interleukin-3 (IL-3; 10 ng/ml, PeptroTech) and
Erythropoietin (EPO; 2 U/ml, Janssen-Cilag), and in some cases
addition of granulocyte-colony stimulating factor (G-CSF;10 ng/ml,
Amgen). Wells were evaluated for colony size and type by light micros-
copy after 4, 7, and 11 days in culture. Lineage potentials were evalu-
ated in semisolid agar cultures (Metcalf, 2004) or methylcellulose. Indi-
cated cell numbers and cell types were seeded in either serum
containingmethylcellulose-basedmedium (M3434, StemCell Technol-
ogies Inc., Vancouver, Canada) or agar-based medium supplied with
growth factors as indicated above. Colonies generated in methylcellu-
lose were scored as CFU-E (3 days after seeding) or BFU-E, GM, Meg,
mixed Meg, and E or GM by morphologic criteria 7 days after seeding.
Agar cultures were performed as described (Metcalf, 2004) with some
minor modifications. In short, 0.6% BactoAgar 2X (Becton Dickinson)
was mixed with preheated DMEM 2X (Chemicon), supplemented with
sodium pyruvate (Sigma) and sodium bicarbonate (Sigma), FCS, and
cytokines as above and kept at 37C. Sorted cells were added, and
1 ml was plated in quadruplicates in 25 mm Petri dishes. After 7
days, cultures were fixed with glutaraldehyde (Fluka) and thereafter
floated in a water bath and dried onto a glass slide and subsequently
stained for (I) 4 hr for acethylcholinesterase (components: trisodium
citrate [Sigma], copper sulfate pentahydrate [Sigma], potassium ferri-
cyanide [Sigma], disodiumhydrogen orthophosphate [Fluka], sodium-
dihydrogen orthophosphate [Fluka] and acethylthiocholine iodide
[Sigma]), (II) 1.5 hr luxol fast stain (Luxol fast blue powder [Sigma],
Urea [Fluka], 70% alcohol), followed by (III) 2 min of hematoxylin stain-
ing (hematoxylin [Sigma], sodium iodide [Sigma], potassium aluminum
sulfate [Sigma], chloral hydrate [Sigma], and citric acid [Sigma]). Slides
were mounted with coverslips using DePex. Thereafter, numbers and
types of generated colonies were determined by light microscopy.
Sorted progenitor cells were cultured in stroma-supported cultures
(OP9) and analyzed for lineage potentials. Briefly OP9 cells (kindly
provided by Drs. A. Cumano, Paris) were maintained in OptiMEM
with L-Glutamine (Invitrogen, Carlsbad, California), supplemented
with 10% FCS. Cell lines were trypsinized and plated at a density of
2 3 104 cells/ml 4–5 hr prior to addition of cells. Immediately prior
to addition of cells, medium was removed from stroma and indicated
sorted progenitor cells (500 of each type) were plated in quadrupli-
cates in 250 ml medium supplemented with cytokines as above. After
5 days of culture, cells were harvested, washed, and stained with
indicated antibodies and analyzed by flow cytometry.
Transplantation Experiments
Cellswere transplanted at indicated cell numbers into sublethally irradi-
ated recipients to evaluate their in vivo capacities to generate granulo-
cytes or platelets. We transplanted 1.53 106 whole bone marrow cells
or the estimated number of sorted hematopoietic stem and progenitor
cells contained within 1.53 106 whole bone marrow cells. At indicated
time points, blood samples were evaluated by flow cytometry for the
levels of GFP+CD150+ positive platelets, and GFP-positive granulo-
cytes were identified by their distinct forward and side scatter profile.
For granulocyte analysis, peripheral blood was obtained from the tail
vein and red blood cells sedimented with 2% Dextran T-500 (Pharma-
cia, Uppsala, Sweden), and remaining red blood cells were lysed with
ammonium chloride. For platelet analysis, whole peripheral blood was
shortly centrifuged and platelet-containing supernatant was stained
withantibodiesagainstCD150 (Nandaet al., 2005) andevaluatedbased
on their small size, CD150 expression, and donor/host origin (GFP/non-
GFP). Erythroid potential was determined by transplantation of lethally
irradiated recipients with indicated cell populations (2500 cells or
250 cells for HSC containing fraction). Reticulocyte counts were deter-
mined at the Stanford University laboratory animal facilities. For gener-
ation of CFU-S8, an assay that primarily detects erythroid production
(Na Nakorn et al., 2002), macroscopic evaluation of spleens obtained
from lethally irradiated mice and transplanted with indicated cell frac-
tions were performed after fixation in Tellesniczky’s fixative.440 Cell Stem Cell 1, 428–442, October 2007 ª2007 Elsevier IncQuantitative RT-PCR and Multiplex Single-Cell RT-PCR
For quantitative (q)RT-PCR, total RNA was isolated with an RNeasy
mini kit (QIAGEN) or by Trizol reagent (Invitrogen) from purified hema-
topoietic cells, digested with DNase I to remove genomic DNA con-
tamination, and used for reverse-transcription with random hexamers
according to themanufacturer’s instructions (SuperScript II kit, Invitro-
gen). Real-time PCR reactions were performed with 200–500 cell
equivalents of RNA in an ABI 7000 sequence detection system using
the 2XSYBR green master mix according to the manufacturer’s in-
structions (PE Applied Biosystems, Foster City, CA). Fold expression
relative to unfractionated BM cells after b-actin normalization was cal-
culated by using the comparative Ct (2-DDCt) method. For the quanti-
tative RT-PCR (qRT-PCR) analyses in Figure 7C, we used ABI (Foster
City, CA) Taqman assay on demand primers and probes. Triplicate
real-time PCR reactions were performed with 100 cell equivalents of
RNA and normalized to b-actin (for comparative purposes to array
data, array data were also normalized to b-actin). Multiplex single-
cell RT-PCR was performed as described by Hu et al. (1997). Single
hematopoietic cells were deposited into 96-well plates containing
4 ml lysis buffer (0.4% Nonidet P-40, 65 mol/l dNTPs, 25 mol/l dithio-
threitol, and 0.5 U/ml RNaseOUT) (Invitrogene Corporation, California).
Cell lysates were reverse transcribed with six pairs of gene-specific re-
verse primers (against c-kit, Mpo, Mpl, Vwfh, Epor, and Klf1) and 50 U
MMLV-RT per reaction in the buffer provided by the supplier (Invitro-
gen Corporation, California). The first-round PCR was performed by
addition of 40 ml PCR buffer containing dNTPs, forward outside
primers, and Taq polymerase (TaKaRa Bio Inc., Shiga, Japan) and
run for 35 cycles. One-microliter aliquots of first-round PCRs were
further amplified with fully nested gene-specific primers. Primer se-
quences are available upon request. Aliquots of second-round PCR
products were subjected to gel electrophoresis and visualized by
ethidium bromide staining on ordinary agarose gels or E gels (Invitro-
gen). c-kit gene product was used as positive internal control.
Affymetrix Gene Expression and Data Analysis
RNA was extracted from purified adult BM subsets with an RNeasy
mRNA purification kit (QIAGEN). Subsequent handling was performed
at the SweGene Affymetrix unit at Lund University (http://www.lth.se/
index.php?id=11754). Briefly, RNA (arrays in triplicate for all progenitor
fractions except for Pre MegE for which five arrays were produced)
was labeled and amplified according to Affymetrix Small Sample
Labeling Protocol v.2, with the exception that the second round of
in vitro transcription (IVT) was performed with an Affymetrix GeneChip
Expression 30-Amplification kit. Hybridization and washing was per-
formed according to Affymetrix GeneChip Expression analysis techni-
cal manual. Chips were scanned with an Affymetrix GeneChip Scanner
3000 and scaled to amedian intensity of 100. For subsequent analysis,
probe level expression values were extracted by using RMA (Irizarry
et al., 2003), and subsequent analyses were performed with dChip
software (http://biosun1.harvard.edu/complab/dchip/) after filtering
(0.5 < SD/mean < 1,000).
Supplemental Data
Supplemental Data include one figure and two tables and can be found
with this article online at http://www.cellstemcell.com/cgi/content/full/
1/4/428/DC1/.
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